A kind of furatriptan succinate sustained-release microspheres and preparation method thereof

A technology of succinic acid and furotril, which can be used in pharmaceutical formulations, medical preparations without active ingredients, and medical preparations containing active ingredients, etc., can solve the problems of high recurrence rate, short half-life, inconvenient to carry and use, etc. , to achieve good treatment effect, improve patient compliance, and enhance the effect of curative effect

Active Publication Date: 2019-10-01
CP PHARMA QINGDAO CO LTD
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

As a second-generation triptan drug, it overcomes the disadvantages of low oral bioavailability, short half-life and high relapse rate of the first-generation 5-HT1B / 1D receptor agonists
At present, there are mainly furovatriptan succinate tablets and injections on the market in our country. Although conventional tablets are convenient to take, they are affected by factors such as disintegration and drug release, and the absorption effect is not ideal. multiple doses
Although the curative effect of the injection is fast, it is inconvenient to carry and use.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of furatriptan succinate sustained-release microspheres and preparation method thereof
  • A kind of furatriptan succinate sustained-release microspheres and preparation method thereof
  • A kind of furatriptan succinate sustained-release microspheres and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

Embodiment 2

Embodiment 3

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
release amountaaaaaaaaaa
Login to view more

Abstract

The invention provides a frovatriptan succinate sustained-release microsphere, which consists of frovatriptan succinate and PLGA, wherein the weight ratio of the frovatriptan succinate to the PLGA is at 1: (1-15); and the frovatriptan succinate accounts for 15.9-23.7% in terms of the total weight of the microsphere, wherein in the PLGA, the molar ratio of lactic acid to glycolic acid is at (75-50): (25-50). With the application of the microsphere, an effective blood concentration can be kept for a relatively long time, the compliance of patients can be improved and a curative effect can be enhanced; and importantly, the microsphere is safe and controllable.

Description

Technical field The invention relates to a sustained-release furotriptan succinate preparation and a preparation method thereof. Background technique Furotriptan succinate, also called frovatriptan succinate, Chinese chemical name (R)-3-(methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6- Formamide succinic acid. Furotriptan succinate is a new anti-migraine drug. This product mainly acts on the extracerebral arteries and intracranial arteries, and inhibits the excessive expansion of these blood vessels. As a second-generation triptan drug, it overcomes the shortcomings of the first-generation 5-HT1B / 1D receptor agonist of low oral bioavailability, short half-life and high recurrence rate. At present, there are mainly furotriptan succinate tablets and injections on the market in my country. Although conventional tablets are convenient to take, they are affected by factors such as disintegration and drug release. The absorption effect is not ideal, and they are often needed in the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/52A61K31/403A61K47/34A61K47/32A61K47/04A61P25/06
Inventor 陈阳生王明刚刘晓霞孙桂玉臧云龙
Owner CP PHARMA QINGDAO CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products